As of 10:31 AM on the 23rd, Celltrion is trading at 361,500 KRW, up 0.7% from the previous day. This is a 10.41% decrease compared to December 7. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners are tentatively recorded as net buyers of 7,000 shares. Over the past five days, individual investors have net sold 322,101 shares, while foreigners and institutions have net bought 209,678 shares and 114,770 shares, respectively.


On December 20, Celltrion was an issue in the market with the headline "Global '7 trillion KRW' market target... Global autoimmune disease treatment..."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing